Erlotinib ( DrugBank: Erlotinib )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
94	原発性硬化性胆管炎	1

94. 原発性硬化性胆管炎

臨床試験数 : 148 / 薬物数 : 118 - (DrugBank : 39) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00955149 (ClinicalTrials.gov)	August 2009	5/8/2009	Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)	An Open Label Pilot Trial of Erlotinib (Tarceva) in Primary Sclerosing Cholangitis With Trisomy 7	Primary Sclerosing Cholangitis;Trisomy 7;Cholangiocarcinoma;Chemoprevention	Drug: Erlotinib (Tarceva)	Mayo Clinic	Genentech, Inc.	Completed	18 Years	N/A	Both	6	Phase 1	United States

First Previous1Next Last